Health Condition 1: L80- Vitiligo
Conditions
Interventions
Intervention1: Arsenicum Sulphuricum Flavum: Started with 6c potency in each case.
Route of drug administration - oral.
Repetition of dosages will be done on the basis of requirement of case as per t
Sponsors
Dr Ankita Jain
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient suffering from vitiligo. 2.Both sexes of age group 5 years to 65 years. 3.Patient willing to give voluntary written informed assent and consent (greater than 18 years).
Exclusion criteria
Exclusion criteria: 1.Vitiligo patients suffering from any life-threatening illness who are terminally ill, under immuno-suppressive treatment or self-reported immuno-compromised state. 2.Patients of malignancy or too sick for consultation. 3.Diagnosed case of mental illness / psychiatric/ other uncontrolled/ life threatening illness affecting quality of life/any organ failure. 4.Pregnant ladies are excluded. 5.Unwilling to take part and not giving consent to join the study. Patients unable to comply with the study protocol. Substance abuse and or dependence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that there will be repigmentation in depigmented area of skin with the individualized homoeopathic medicines compared to Arsenicum Sulphuricum Flavum in vitiligo.Timepoint: At baseline (0 weeks) and after 9 months(36 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that there will be improvement in patient’s outcome and general well being, without any substantial medicinal adverse effects hence an improvement in quality of life (DLQI) & significant reduction in VASI scores and Re-pigmentation on hypopigmented/ depigmented patches.Timepoint: At baseline (0 weeks) and after 9 months (36 weeks) | — |
Countries
India
Contacts
Public ContactDr Ankita Jain
Dr B R Sur Homoeopathic Medical College Hospital And Research Centre, Nanakpura Motibagh
Outcome results
None listed